Literature DB >> 12562932

Ketamine increases human motor cortex excitability to transcranial magnetic stimulation.

V Di Lazzaro1, A Oliviero, P Profice, M A Pennisi, F Pilato, G Zito, M Dileone, R Nicoletti, P Pasqualetti, P A Tonali.   

Abstract

Subanaesthetic doses of the N-methyl-D-aspartate (NMDA) antagonist ketamine have been shown to determine a dual modulating effect on glutamatergic transmission in experimental animals, blocking NMDA receptor activity and enhancing non-NMDA transmission through an increase in the release of endogenous glutamate. Little is known about the effects of ketamine on the excitability of the human central nervous system. The effects of subanaesthetic, graded incremental doses of ketamine (0.01, 0.02 and 0.04 mg kg-1 min-1, I.V.) on the excitability of cortical networks of the human motor cortex were examined with a range of transcranial magnetic and electric stimulation protocols in seven normal subjects. Administration of ketamine at increasing doses produced a progressive reduction in the mean resting motor threshold (RMT) (F(3, 18) = 22.33, P < 0.001) and active motor threshold (AMT) (F(3, 18) = 12.17, P < 0.001). Before ketamine administration, mean RMT +/- S.D. was 49 +/- 3.3 % of maximum stimulator output and at the highest infusion level it was 42.6 +/- 2.6 % (P < 0.001). Before ketamine administration, AMT +/- S.D. was 38 +/- 3.3 % of maximum stimulator output and at the highest infusion level it was 33 +/- 4.4 % (P < 0.002). Ketamine also led to an increase in the amplitude of EMG responses evoked by magnetic stimulation at rest; this increase was a function of ketamine dosage (F(3, 18) = 5.29, P = 0.009). In contrast to responses evoked by magnetic stimulation, responses evoked by electric stimulation were not modified by ketamine. The differential effect of ketamine on responses evoked by magnetic and electric stimulation demonstrates that subanaesthetic doses of ketamine enhance the recruitment of excitatory cortical networks in motor cortex. Transcranial magnetic stimulation produces a high-frequency repetitive discharge of pyramidal neurones and for this reason probably depends mostly on short-lasting AMPA transmission. An increase in this transmission might facilitate the repetitive discharge of pyramidal cells after transcranial magnetic stimulation which, in turn, results in larger motor responses and lower thresholds. We suggest that the enhancement of human motor cortex excitability to transcranial magnetic stimulation is the effect of an increase in glutamatergic transmission at non-NMDA receptors similar to that described in experimental studies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12562932      PMCID: PMC2342642          DOI: 10.1113/jphysiol.2002.030486

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  36 in total

1.  Direct demonstration of the effect of lorazepam on the excitability of the human motor cortex.

Authors:  V Di Lazzaro; A Oliviero; M Meglio; B Cioni; G Tamburrini; P Tonali; J C Rothwell
Journal:  Clin Neurophysiol       Date:  2000-05       Impact factor: 3.708

2.  Interactions between two different inhibitory systems in the human motor cortex.

Authors:  T D Sanger; R R Garg; R Chen
Journal:  J Physiol       Date:  2001-01-15       Impact factor: 5.182

3.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

4.  Intracortical origin of the short latency facilitation produced by pairs of threshold magnetic stimuli applied to human motor cortex.

Authors:  V Di Lazzaro; J C Rothwell; A Oliviero; P Profice; A Insola; P Mazzone; P Tonali
Journal:  Exp Brain Res       Date:  1999-12       Impact factor: 1.972

5.  Kainate receptors regulate unitary IPSCs elicited in pyramidal cells by fast-spiking interneurons in the neocortex.

Authors:  A B Ali; J Rossier; J F Staiger; E Audinat
Journal:  J Neurosci       Date:  2001-05-01       Impact factor: 6.167

6.  Steps in production of motoneuron spikes during rhythmic firing.

Authors:  W H Calvin; P C Schwindt
Journal:  J Neurophysiol       Date:  1972-05       Impact factor: 2.714

7.  Ketamine-induced electroconvulsive phenomena in the human limbic and thalamic regions.

Authors:  T Ferrer-Allado; V L Brechner; A Dymond; H Cozen; P Crandall
Journal:  Anesthesiology       Date:  1973-04       Impact factor: 7.892

8.  Ketamine-induced changes in kindled amygdaloid seizures.

Authors:  J F Bowyer; T E Albertson; W D Winters; R C Baselt
Journal:  Neuropharmacology       Date:  1983-07       Impact factor: 5.250

9.  The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate.

Authors:  N A Anis; S C Berry; N R Burton; D Lodge
Journal:  Br J Pharmacol       Date:  1983-06       Impact factor: 8.739

Review 10.  Shaping excitation at glutamatergic synapses.

Authors:  F Conti; R J Weinberg
Journal:  Trends Neurosci       Date:  1999-10       Impact factor: 13.837

View more
  64 in total

Review 1.  Inhibition of the cortex using transcranial magnetic stimulation in psychiatric populations: current and future directions.

Authors:  Natasha Radhu; Lakshmi N Ravindran; Andrea J Levinson; Zafiris J Daskalakis
Journal:  J Psychiatry Neurosci       Date:  2012-11       Impact factor: 6.186

2.  Post-stroke fatigue: a deficit in corticomotor excitability?

Authors:  Annapoorna Kuppuswamy; Ella V Clark; Isobel F Turner; John C Rothwell; Nick S Ward
Journal:  Brain       Date:  2014-11-02       Impact factor: 13.501

3.  Neuronavigation increases the physiologic and behavioral effects of low-frequency rTMS of primary motor cortex in healthy subjects.

Authors:  S Bashir; D Edwards; A Pascual-Leone
Journal:  Brain Topogr       Date:  2010-11-13       Impact factor: 3.020

4.  Physiology of modulation of motor cortex excitability by low-frequency suprathreshold repetitive transcranial magnetic stimulation.

Authors:  G Heide; O W Witte; U Ziemann
Journal:  Exp Brain Res       Date:  2005-11-24       Impact factor: 1.972

5.  Modulating parameters of excitability during and after transcranial direct current stimulation of the human motor cortex.

Authors:  Michael A Nitsche; Antje Seeber; Kai Frommann; Cornelia Carmen Klein; Christian Rochford; Maren S Nitsche; Kristina Fricke; David Liebetanz; Nicolas Lang; Andrea Antal; Walter Paulus; Frithjof Tergau
Journal:  J Physiol       Date:  2005-07-07       Impact factor: 5.182

Review 6.  Modulation of motor cortex excitability by sustained peripheral stimulation: the interaction between the motor cortex and the cerebellum.

Authors:  Andreas R Luft; Mario-Ubaldo Manto; Nordeyn Oulad Ben Taib
Journal:  Cerebellum       Date:  2005       Impact factor: 3.847

Review 7.  [Cortical excitability in schizophrenia. Studies using transcranial magnetic stimulation].

Authors:  T Wobrock; D Kadovic; P Falkai
Journal:  Nervenarzt       Date:  2007-07       Impact factor: 1.214

8.  Greater intracortical inhibition associates with lower quadriceps voluntary activation in individuals with ACL reconstruction.

Authors:  Brittney A Luc-Harkey; Matthew S Harkey; Derek N Pamukoff; Rebecca H Kim; Troy K Royal; J Troy Blackburn; Jeffery T Spang; Brian Pietrosimone
Journal:  Exp Brain Res       Date:  2017-01-31       Impact factor: 1.972

9.  Functional evaluation of central cholinergic circuits in patients with Parkinson's disease and REM sleep behavior disorder: a TMS study.

Authors:  Raffaele Nardone; Jürgen Bergmann; Francesco Brigo; Monica Christova; Alexander Kunz; Martin Seidl; Frediano Tezzon; Eugen Trinka; Stefan Golaszewski
Journal:  J Neural Transm (Vienna)       Date:  2012-08-19       Impact factor: 3.575

10.  Left auditory cortex gamma synchronization and auditory hallucination symptoms in schizophrenia.

Authors:  Kevin M Spencer; Margaret A Niznikiewicz; Paul G Nestor; Martha E Shenton; Robert W McCarley
Journal:  BMC Neurosci       Date:  2009-07-20       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.